Also from this source

You just read:

Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

News provided by

WuXi PharmaTech (Cayman) Inc.

May 21, 2015, 07:00 ET